The Zurich-based startup, which previously raised €3M to unify fragmented trial data, has secured a larger round to build AI agents that actively manage the complex operational layer of running a clinical trial. Clinical trials are, by almost any measure, one of the most information-intensive processes in modern medicine, and one of the least efficiently […]
This story continues at The Next Web